Gwendalyn Randolph
Appearances
DateMay 7, 2023The pathogenesis of inflammatory bowel disease (IBD) involves crosstalk between genetic and microbial factors that influence immune reactions. Tofacitinib, a pan JAK-STAT inhibitor, is a small molecule indicated for the treatment of moderate-to-severe ulcerative colitis (UC)…Presenter
Speakers
University Hospitals LeuvenIcahn School of Medicine at Mount SinaiIcahn School of Medicine at Mount Sinai- DateMay 20, 2024
Presenter
DateMay 18, 2024SOCIETY: AGA Dynamic metabolic responses drive alterations to cellular and tissue homeostasis. This session will identify metabolic regulation of inflammation, tumorigenesis, and tissue injury in the GI tract, pancreas, and liver…Moderators
Vanderbilt Unversity Medical CenterUniversity of Kentucky
